Remedium Lifecare soars on receiving contract from pharmaceutical distribution company in UK

25 Jun 2024 Evaluate

Remedium Lifecare is currently trading at Rs. 70.27, up by 3.24 points or 4.83% from its previous closing of Rs. 67.03 on the BSE.

The scrip opened at Rs. 71.20 and has touched a high and low of Rs. 73.40 and Rs. 69.89 respectively. So far 257470 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 179.66 on 02-Aug-2023 and a 52 week low of Rs. 66.25 on 20-Jun-2024.

Last one week high and low of the scrip stood at Rs. 73.40 and Rs. 66.25 respectively. The current market cap of the company is Rs. 710.14 crore.

The promoters holding in the company stood at 1.11%, while Institutions and Non-Institutions held 0.04% and 98.85% respectively.

Remedium Lifecare has received a multi-year supply contract from a pharmaceutical distribution company based in the United Kingdom (UK). The contract involves the supply of various Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty Chemicals. The supplies scheduled between July 2024 and June 2025 alone are valued at Rs 175 crore. 

Remedium Lifecare is pharmaceutical company aligned across two business verticals viz. Products and Services.

Supha Pharmachem Share Price

0.87 0.06 (7.41%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 263.55
Adani Enterprises 2156.70
Amrapali Industries 14.50
Rashi Peripheral 368.00
PDS 347.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×